相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Highly Efficient and Selective CAR-Gene Transfer Using CD4-and CD8-Targeted Lentiviral Vectors
Arezoo Jamali et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Surface-Engineered Lentiviral Vectors for Selective Gene Transfer into Subtypes of Lymphocytes
Annika M. Frank et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Standard screening methods underreport AAV-mediated transduction and gene editing
Jonathan F. Lang et al.
NATURE COMMUNICATIONS (2019)
Extracellular vesicles: nature's nanoparticles for improving gene transfer with adeno-associated virus vectors
Bence Gyorgy et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2018)
In vivo generation of human CD19-CAR T cells results in B-cell depletion and signs of cytokine release syndrome
Anett Pfeiffer et al.
EMBO MOLECULAR MEDICINE (2018)
High Prevalence of Infectious Adeno-associated Virus (AAV) in Human Peripheral Blood Mononuclear Cells Indicative of T Lymphocytes as Sites of AAV Persistence
Daniela Hueser et al.
JOURNAL OF VIROLOGY (2017)
Systemic and Persistent Muscle Gene Expression in Rhesus Monkeys with a Liver De-Targeted Adeno-Associated Virus Vector
Alice F. Tarantal et al.
HUMAN GENE THERAPY (2017)
Rescue of Hearing by Gene Delivery to Inner-Ear Hair Cells Using Exosome-Associated AAV
Bence Gyorgy et al.
MOLECULAR THERAPY (2017)
First AAV gene therapy poised for landmark approval
Eric Smalley
NATURE BIOTECHNOLOGY (2017)
Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
Stephen J. Schuster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy
Florian Eichler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
J. R. Mendell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant
L. A. George et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
AAV5-Factor VIII Gene Transfer in Severe Hemophilia A
Savita Rangarajan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Exosome-associated AAV2 vector mediates robust gene delivery into the murine retina upon intravitreal injection
Sarah J. Wassmer et al.
SCIENTIFIC REPORTS (2017)
Enhanced liver gene transfer and evasion of preexisting humoral immunity with exosome-enveloped AAV vectors
Amine Meliani et al.
BLOOD ADVANCES (2017)
Exosome-associated AAV vector as a robust and convenient neuroscience tool
E. Hudry et al.
GENE THERAPY (2016)
Exclusive Transduction of Human CD4+ T Cells upon Systemic Delivery of CD4-Targeted Lentiviral Vectors
Qi Zhou et al.
JOURNAL OF IMMUNOLOGY (2015)
Efficient and Targeted Transduction of Nonhuman Primate Liver With Systemically Delivered Optimized AAV3B Vectors
Shaoyong Li et al.
MOLECULAR THERAPY (2015)
Comparative analyses of adeno-associated viral vector serotypes 1, 2, 5, 8 and 9 in marmoset, mouse and macaque cerebral cortex
Akiya Watakabe et al.
NEUROSCIENCE RESEARCH (2015)
Off-target-free gene delivery by affinity-purified receptor-targeted viral vectors
Robert C. Muench et al.
NATURE COMMUNICATIONS (2015)
Naturally enveloped AAV vectors for shielding neutralizing antibodies and robust gene delivery in vivo
Bence Gyoergy et al.
BIOMATERIALS (2014)
A Modified γ-Retrovirus Vector for X-Linked Severe Combined Immunodeficiency
S. Hacein-Bey-Abina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B
A. C. Nathwani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
A Single Intravenous rAAV Injection as Late as P20 Achieves Efficacious and Sustained CNS Gene Therapy in Canavan Mice
Seemin Seher Ahmed et al.
MOLECULAR THERAPY (2013)
Microvesicle-associated AAV Vector as a Novel Gene Delivery System
Casey A. Maguire et al.
MOLECULAR THERAPY (2012)
AAV2 Gene Therapy Readministration in Three Adults with Congenital Blindness
Jean Bennett et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Optimization of lentiviral vector transduction into peripheral blood mononuclear cells in combination with the fibronectin fragment CH-296 stimulation
Hideto Chono et al.
JOURNAL OF BIOCHEMISTRY (2011)
Risk factors in the development of stem cell therapy
Carla A. Herberts et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Continuous CD8+ T-Cell Priming by Dendritic Cell Cross-Presentation of Persistent Antigen following Adeno-Associated Virus-Mediated Gene Delivery
Dan Xu et al.
JOURNAL OF VIROLOGY (2011)
AAV6-mediated Systemic shRNA Delivery Reverses Disease in a Mouse Model of Facioscapulohumeral Muscular Dystrophy
Sergia Bortolanza et al.
MOLECULAR THERAPY (2011)
MicroRNA-regulated, Systemically Delivered rAAV9: A Step Closer to CNS-restricted Transgene Expression
Jun Xie et al.
MOLECULAR THERAPY (2011)
Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial
Albert M. Maguire et al.
LANCET (2009)
Efficient Intrathymic Gene Transfer Following In Situ Administration of a rAAV Serotype 8 Vector in Mice and Nonhuman Primates
Aurelie Moreau et al.
MOLECULAR THERAPY (2009)
Adeno-associated virus vector Genomes persist as episomal chromatin in primate muscle
Magalie Penaud-Budloo et al.
JOURNAL OF VIROLOGY (2008)
Limited efficacy of gene transfer in herpes simplex virus-thymidine kinase/ganciclovir gene therapy for brain tumors
P Hadaczek et al.
JOURNAL OF NEUROSURGERY (2005)
Integration of adeno-associated virus (AAV) and recombinant AAV vectors
DM McCarty et al.
ANNUAL REVIEW OF GENETICS (2004)
Specific transgene expression in human and mouse CD4+ cells using lentiviral vectors with regulatory sequences from the CD4 gene
G Marodon et al.
BLOOD (2003)
Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo
H Nakai et al.
JOURNAL OF VIROLOGY (2001)
分享论文
